A Conditional Application for a New Vasculitis Treatment Was Just Accepted By The EMA
source: pixabay.com

A Conditional Application for a New Vasculitis Treatment Was Just Accepted By The EMA

According to a story from ANCA Vasculitis News, The European Medicines Agency just approved the pharmaceutical company ChemoCentryx's application for the marketing of avacopan as a potential treatment for anti-neutrophil…

Continue Reading A Conditional Application for a New Vasculitis Treatment Was Just Accepted By The EMA